Management and company info
CVR: 40549889
Not available
No owners listed
CVR · view owners
Board: 5 members
CVR · view management
Active
Founded 28 May 2019
CVR · view overview
12 employees
CVR · 2026
Name registered: Chiesi Pharma Danmark, filial af Chiesi Pharma AB
CVR · 28/05/2019
View the full event history
Chiesi Pharma Danmark, filial af Chiesi Pharma AB is a Danish company of the type Filial af udenlandsk anpartsselskab eller selskab based in København Ø, founded in 2019. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The board consists of Filiz Balcay, Giulia Cuccagna, Helena Bergström and Michael Russell Gordon. The company has 12 employees (2026).
Filialens formål er markedsføring af lægemidler i Danmark, samt dermed beslægtet virksomhed.
No annual financial figures are available for this company.
Screen owners and management against the Danish FSA's official PEP lists
1 public tender won
Sources: TED (the EU tender database) and udbud.dk
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningThe CVR number of Chiesi Pharma Danmark, filial af Chiesi Pharma AB is 40549889.
The board of Chiesi Pharma Danmark, filial af Chiesi Pharma AB consists of Filiz Balcay, Giulia Cuccagna and Helena Bergström.
Chiesi Pharma Danmark, filial af Chiesi Pharma AB had 12 employees in 2026 according to the Danish CVR register.
Chiesi Pharma Danmark, filial af Chiesi Pharma AB was founded on 28 May 2019.
Chiesi Pharma Danmark, filial af Chiesi Pharma AB is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler (industry code 464610).
Chiesi Pharma Danmark, filial af Chiesi Pharma AB is located at c/o Grant Thornton, Lautrupsgade 11, 2100 København Ø.
Claim this page to add your logo and social links. Free to get started.
Chiesi Pharma Danmark, filial af Chiesi Pharma AB has published its annual report for 2025.
Chiesi Pharma Danmark, filial af Chiesi Pharma AB has published its annual report for 2024.
As of April 15, 2025, Giulia Cuccagna has joined the board of directors of Chiesi Pharma Danmark, filial af Chiesi Pharma AB.
As of April 15, 2025, Véronique Magro has left the board of directors of Chiesi Pharma Danmark, filial af Chiesi Pharma AB.
Chiesi Pharma Danmark, filial af Chiesi Pharma AB has published its annual report for 2023.
As of April 16, 2024, Filiz Balcay has joined the board of directors of Chiesi Pharma Danmark, filial af Chiesi Pharma AB.
As of April 16, 2024, Michael Russell Gordon has joined the board of directors of Chiesi Pharma Danmark, filial af Chiesi Pharma AB.
As of April 16, 2024, Véronique Magro has joined the board of directors of Chiesi Pharma Danmark, filial af Chiesi Pharma AB.
Chiesi Pharma Danmark, filial af Chiesi Pharma AB has won the tender "Amgros 2024 1.100.a" issued by Amgros I/S worth 61,100,000 DKK.
As of April 1, 2024, Helena Bergström has joined the board of directors of Chiesi Pharma Danmark, filial af Chiesi Pharma AB.
Chiesi Pharma Danmark, filial af Chiesi Pharma AB has published its annual report for 2022.
Chiesi Pharma Danmark, filial af Chiesi Pharma AB has published its annual report for 2021.
Chiesi Pharma Danmark, filial af Chiesi Pharma AB has published its annual report for 2020.
Chiesi Pharma Danmark, filial af Chiesi Pharma AB has published its annual report for 2019.
As of September 8, 2019, Olav Henrik Fromm has left the board of directors of Chiesi Pharma Danmark, filial af Chiesi Pharma AB.
As of May 28, 2019, Olav Henrik Fromm has joined the board of directors of Chiesi Pharma Danmark, filial af Chiesi Pharma AB.
As of May 28, 2019, Olav Henrik Fromm has joined the board of directors of Chiesi Pharma Danmark, filial af Chiesi Pharma AB.
Chiesi Pharma Danmark, filial af Chiesi Pharma AB was founded on May 28, 2019.

Uneven Bits ApS is an independent IT consultancy founded and operated by Klaus Byskov Pedersen. With deep expertise in software architecture and systems design, I help organizations build robust, scalable, and maintainable technical solutions. Whether you need strategic guidance on technology decisions, hands-on architecture work, or help navigating complex technical challenges, I bring focused expertise and a practical approach to every engagement.

Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.


Selskabets formål er IT- og kommunikationsvirksomhed samt virksomhed i øvrigt, der efter bestyrelsens skøn står i forbindelse hermed.

Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Companies in the same industry and area
CVR 46788176
CVR 19064301
CVR 37726508
CVR 44420449
CVR 25361695